Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The Shumin device with doxycycline is more effective for rosacea than red light therapy.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Women with alopecia may have a higher chance of getting thyroid cancer.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Yellow and orange colors are important for diagnosing certain skin conditions.

Hair loss gene linked to prostate issues.

Inconsistent safety reporting in chronic back pain trials risks patient safety and decision-making.

Individualized treatment improves symptoms and quality of life for women with PCOS.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Silk sericin dressing with collagen heals wounds faster and improves scar quality better than Bactigras.

Some breast cancer chemotherapy can cause permanent hair loss.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Dutasteride may help shrink prostate cancer tumors.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Finasteride, often used for hair loss, can potentially cause cataracts.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Breast cancer alters specific molecular structures in hair, which revert after cancer removal.

Oral minoxidil improved hair loss more than oral dutasteride.

The new near-infrared LED device improves skin and hair with no side effects.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.